The photocytotoxicity of a series of anticancer trans-dihydroxido [Pt(N 3 ) 2 (OH) 2 (NH 3 )(X)] (X = alkyl or aryl amine) platinum(IV) diazido complexes has been examined and the influence of cistrans isomerism investigated. A series of photoactivatable Pt IV -azido complexes has been synthesized: the synthesis, characterisation and photocytotoxicity of six mixed-ligand ammine/ amine Pt IV diazido complexes, cis,trans,cis,-[Pt(N 3 ) 2 (OH) 2 (NH 3 )(X)] where X = propylamine (4c), butylamine (5c), pentylamine (6c) and aromatic complexes X= pyridine (7c) 2-methylpyridine (8c), 3-methylpyridine (9c) are reported. Six all-trans isomers have also been studied where X = methylamine (2t), ethylamine (3t), 2-methylpyridine (8t), 4-methylpyridine (10t), 3-methylpyridine (9t) and 2-bromo-3-methylpyridine (11t). All the complexes exhibit intense azide-to-Pt IV LMCT bands (ca. 290 nm for trans and ca. 260 nm for cis). When irradiated with UVA light (365 nm) the Pt IV complexes undergo photoreduction to Pt II species, as monitored by UV-vis spectroscopy. The trans isomers of complexes containing aliphatic or aromatic amines were more photocytotoxic than their cis isomers. One of the cis complexes (9c) was nonphotocytotoxic despite undergoing photoreduction. Substitution of NH 3 ligands by MeNH 2 or EtNH 2 results in more potent photocytotoxicity for the all-trans complexes. The complexes were all non-toxic towards human keratinocytes (HaCaT) and A2780 human ovarian cancer cells in the dark, apart from the 3-methylpyridine (9t) 2-bromo-3-methylpyridine (11t) and 4-methylpyridine (10t) derivatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.